|
1
|
Csupor-Löffler B, Hajdú Z, Zupkó I, Réthy
B, Falkay G, Forgo P and Hohmann J: Antiproliferative effect of
flavonoids and sesquiterpenoids from Achillea millefolium s.1. on
cultured human tumour cell lines. Phytother Res. 23:672–676. 2009.
View Article : Google Scholar
|
|
2
|
Shen JK, Du HP, Yang M, Wang YG and Jin J:
Casticin induces leukemic cell death through apoptosis and mitotic
catastrophe. Ann Hematol. 88:743–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang SY, Zhong MZ, Yuan GJ, Hou SP, Yin
LL, Jiang H and Yu ZY: Casticin, a flavonoid, potentiates
TRAIL-induced apoptosis through modulation of anti-apoptotic
proteins and death receptor 5 in colon cancer cells. Oncol Rep.
29:474–480. 2013.
|
|
4
|
Haïdara K, Zamir L, Shi QW and Batist G:
The flavonoid Casticin has multiple mechanisms of tumor
cytotoxicity action. Cancer Lett. 242:180–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pirollo KF, Bouker KB and Chang EH: Does
p53 status influence tumor response to anticancer therapies?
Anticancer Drugs. 11:419–432. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen D, Cao J, Tian L, Liu F and Sheng X:
Induction of apoptosis by casticin in cervical cancer cells through
reactive oxygen species-mediated mitochondrial signaling pathways.
Oncol Rep. 26:1287–1294. 2011.PubMed/NCBI
|
|
7
|
Deyoung MP and Ellisen LW: p63 and p73 in
human cancer: Defining the network. Oncogene. 26:5169–5183. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang A, Walker N, Bronson R, Kaghad M,
Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, et
al: p73-deficient mice have neurological, pheromonal and
inflammatory defects but lack spontaneous tumours. Nature.
404:99–103. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Melino G, De Laurenzi V and Vousden KH:
p73: Friend or foe in tumorigenesis. Nat Rev Cancer. 2:605–615.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dötsch V, Bernassola F, Coutandin D, Candi
E and Melino G: p63 and p73, the ancestors of p53. Cold Spring Harb
Perspect Biol. 2:a0048872010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jost CA, Marin MC and Kaelin WG Jr: p73 is
a simian [correction of human] p53-related protein that can induce
apoptosis. Nature. 389:191–194. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou B, Chim CS, Pang R, Zeng H, Dai Y,
Zhang R, Lam CS, Tan VP, Hung IF, Lan HY, et al: XIAP-associated
factor 1 (XAF1), a novel target of p53, enhances p53-mediated
apoptosis via post-translational modification. Mol Carcinog.
51:422–432. 2012. View
Article : Google Scholar
|
|
13
|
Liston P, Fong WG, Kelly NL, Toji S,
Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW and Korneluk
RG: Identification of XAF1 as an antagonist of XIAP anti-Caspase
activity. Nat Cell Biol. 3:128–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee MG, Huh JS, Chung SK, Lee JH, Byun DS,
Ryu BK, Kang MJ, Chae KS, Lee SJ, Lee CH, et al: Promoter CpG
hyper-methylation and downregulation of XAF1 expression in human
urogenital malignancies: Implication for attenuated p53 response to
apoptotic stresses. Oncogene. 25:5807–5822. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park GB, Kim YS, Kim D, Kim S, Lee HK, Cho
DH, Lee WJ and Hur DY: Melphalan-induced apoptosis of
EBV-transformed B cells through upregulation of TAp73 and XAF1 and
nuclear import of XPA. J Immunol. 191:6281–6291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Declercq W, Vanden Berghe T and
Vandenabeele P: RIP kinases at the crossroads of cell death and
survival. Cell. 138:229–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho YS, Challa S, Moquin D, Genga R, Ray
TD, Guildford M and Chan FK: Phosphorylation-driven assembly of the
RIP1-RIP3 complex regulates programmed necrosis and virus-induced
inflammation. Cell. 137:1112–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Yu W, Hu Z, Jia L, Iyer VR,
Sanders BG and Kline K: Involvement of JNK/p73/NOXA in vitamin E
analog-induced apoptosis of human breast cancer cells. Mol
Carcinog. 47:436–445. 2008. View
Article : Google Scholar
|
|
19
|
Sanchez-Prieto R, Sanchez-Arevalo VJ,
Servitja JM and Gutkind JS: Regulation of p73 by c-Abl through the
p38 MAP kinase pathway. Oncogene. 21:974–979. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Yang Y, Tian L, Sheng XF, Liu F
and Cao JG: Casticin-induced apoptosis involves death receptor 5
upregulation in hepatocellular carcinoma cells. World J
Gastroenterol. 17:4298–4307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin Y, Choksi S, Shen HM, Yang QF, Hur GM,
Kim YS, Tran JH, Nedospasov SA and Liu ZG: Tumor necrosis
factor-induced nonapoptotic cell death requires
receptor-interacting protein-mediated cellular reactive oxygen
species accumulation. J Biol Chem. 279:10822–10828. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaiser WJ and Offermann MK: Apoptosis
induced by the toll-like receptor adaptor TRIF is dependent on its
receptor interacting protein homotypic interaction motif. J
Immunol. 174:4942–4952. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Müller M, Schilling T, Sayan AE, Kairat A,
Lorenz K, Schulze-Bergkamen H, Oren M, Koch A, Tannapfel A,
Stremmel W, et al: TAp73/Delta Np73 influences apoptotic response,
chemosensitivity and prognosis in hepatocellular carcinoma. Cell
Death Differ. 12:1564–1577. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liston P, Roy N, Tamai K, Lefebvre C,
Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE,
MacKenzie A, et al: Suppression of apoptosis in mammalian cells by
NAIP and a related family of IAP genes. Nature. 379:349–353. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arora V, Cheung HH, Plenchette S, Micali
OC, Liston P and Korneluk RG: Degradation of survivin by the
X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J Biol Chem.
282:26202–26209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fong WG, Liston P, Rajcan-Separovic E, St
Jean M, Craig C and Korneluk RG: Expression and genetic analysis of
XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics.
70:113–122. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ju WC, Huang GB, Luo XY, Ren WH, Zheng DQ,
Chen PJ, Lou YF and Li B: X-linked inhibitor of
apoptosis-associated factor l (XAFl) enhances the sensitivity of
colorectal cancer cells to cisplatin. Med Oncol. 31:2732014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Straszewski-Chavez SL, Visintin IP,
Karassina N, Los G, Liston P, Halaban R, Fadiel A and Mor G: XAF1
mediates tumor necrosis factor-alpha-induced apoptosis and X-linked
inhibitor of apoptosis cleavage by acting through the mitochondrial
pathway. J Biol Chem. 282:13059–13072. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Wu G, Cao G, Yang L, Xu H, Huang J
and Hou J: Zoledronic acid inhibits the pentose phosphate pathway
through attenuating the Ras-TAp73-G6PD axis in bladder cancer
cells. Mol Med Rep. 12:4620–4625. 2015.PubMed/NCBI
|
|
30
|
Zhang Y, Yan W, Jung YS and Chen X:
Mammary epithelial cell polarity is regulated differentially by p73
isoforms via epithelial-to-mesenchymal transition. J Biol Chem.
287:17746–17753. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sayan AE, D'Angelo B, Sayan BS, Tucci P,
Cimini A, Cerù MP, Knight RA and Melino G: p73 and p63 regulate the
expression of fibroblast growth factor receptor 3. Biochem Biophys
Res Commun. 394:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang D, Lin J and Han J:
Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol.
7:243–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stanger BZ, Leder P, Lee TH, Kim E and
Seed B: RIP: A novel protein containing a death domain that
interacts with Fas/APO-1 (CD95) in yeast and causes cell death.
Cell. 81:513–523. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chaudhary PM, Eby M, Jasmin A, Bookwalter
A, Murray J and Hood L: Death receptor 5, a new member of the TNFR
family, and DR4 induce FADD-dependent apoptosis and activate the
NF-kappaB pathway. Immunity. 7:821–830. 1997. View Article : Google Scholar
|
|
35
|
Festjens N, Vanden Berghe T, Cornelis S
and Vandenabeele P: RIP1, a kinase on the crossroads of a cell's
decision to live or die. Cell Death Differ. 14:400–410. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin Y, Devin A, Cook A, Keane MM, Kelliher
M, Lipkowitz S and Liu ZG: The death domain kinase RIP is essential
for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun
N-terminal kinase. Mol Cell Biol. 20:6638–6645. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
